Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China
· Delayed Price · Currency is CNY 22.41
-0.29 (-1.28%)
Apr 2, 2025, 2:45 PM CST
SHE:002262 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,144 | 1,037 | 900.71 | 797.78 | 728.82 | Upgrade
|
| Depreciation & Amortization | 181.73 | 164.08 | 148.66 | 135.06 | 96.83 | Upgrade
|
| Other Amortization | 52.47 | 11.01 | 5.09 | 2.78 | 2.5 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.29 | -0.15 | -0.37 | 0.24 | 0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.07 | -0.22 | 0.28 | 0.74 | 1.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | -65.57 | -51.04 | -36.27 | -36.23 | -21.49 | Upgrade
|
| Provision & Write-off of Bad Debts | 33.95 | 15.16 | 1.1 | 6.99 | 2.35 | Upgrade
|
| Other Operating Activities | 40.78 | 34.29 | 2.09 | 42.38 | 18.98 | Upgrade
|
| Change in Accounts Receivable | -512.98 | -199.06 | -155.28 | -122.88 | 475.04 | Upgrade
|
| Change in Inventory | -71.8 | 54.43 | -128.19 | -205.88 | -109.41 | Upgrade
|
| Change in Accounts Payable | 81.71 | -33.91 | 126.92 | 77.1 | 53.05 | Upgrade
|
| Change in Other Net Operating Assets | 31.05 | -0.01 | - | 2.49 | 10.9 | Upgrade
|
| Operating Cash Flow | 916.13 | 1,008 | 861.02 | 701.12 | 1,248 | Upgrade
|
| Operating Cash Flow Growth | -9.14% | 17.11% | 22.81% | -43.84% | 307.99% | Upgrade
|
| Capital Expenditures | -450.06 | -373.99 | -327.75 | -206.11 | -268.61 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.8 | 1.48 | 0.09 | 0.34 | 0.14 | Upgrade
|
| Cash Acquisitions | -0.34 | -0.13 | - | - | -0.9 | Upgrade
|
| Divestitures | - | - | - | 0.15 | 5.78 | Upgrade
|
| Investment in Securities | -1,008 | 37 | -393.6 | -221.4 | -677 | Upgrade
|
| Other Investing Activities | 46.12 | 42.25 | 32.36 | 34.49 | 28.64 | Upgrade
|
| Investing Cash Flow | -1,411 | -293.39 | -688.9 | -392.52 | -911.95 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 38 | Upgrade
|
| Long-Term Debt Issued | 65 | 80 | 40 | 38 | - | Upgrade
|
| Total Debt Issued | 65 | 80 | 40 | 38 | 38 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -38 | Upgrade
|
| Long-Term Debt Repaid | -141.05 | -87.55 | -78.04 | -62.67 | - | Upgrade
|
| Total Debt Repaid | -141.05 | -87.55 | -78.04 | -62.67 | -38 | Upgrade
|
| Net Debt Issued (Repaid) | -76.05 | -7.55 | -38.04 | -24.67 | - | Upgrade
|
| Issuance of Common Stock | 98.86 | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -0.46 | -201.57 | Upgrade
|
| Common Dividends Paid | -323.77 | -202.62 | -201.52 | -100.76 | -101.91 | Upgrade
|
| Other Financing Activities | - | - | -1.22 | -1.54 | -1.59 | Upgrade
|
| Financing Cash Flow | -300.97 | -210.17 | -240.78 | -127.43 | -305.07 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.17 | 0.41 | 0.91 | -1.14 | -0.38 | Upgrade
|
| Net Cash Flow | -796.15 | 505.15 | -67.75 | 180.02 | 30.95 | Upgrade
|
| Free Cash Flow | 466.07 | 634.31 | 533.27 | 495.01 | 979.74 | Upgrade
|
| Free Cash Flow Growth | -26.52% | 18.95% | 7.73% | -49.48% | 572.56% | Upgrade
|
| Free Cash Flow Margin | 8.18% | 12.58% | 12.41% | 12.58% | 29.15% | Upgrade
|
| Free Cash Flow Per Share | 0.46 | 0.63 | 0.53 | 0.49 | 0.97 | Upgrade
|
| Cash Interest Paid | - | - | 4.95 | 5.06 | 1.59 | Upgrade
|
| Cash Income Tax Paid | 738.14 | 677.61 | 543.1 | 545.21 | 470.14 | Upgrade
|
| Levered Free Cash Flow | 354.32 | 367.44 | 221.79 | 245.59 | 330.6 | Upgrade
|
| Unlevered Free Cash Flow | 356.84 | 370.04 | 224.88 | 248.76 | 331.59 | Upgrade
|
| Change in Net Working Capital | 216.66 | 99.56 | 164.63 | 215.03 | -1.51 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.